Micro-Scholarship, What it is, How can it help me.pdf
DR. MYM pathology for PHO unit 8.pptx
1. Unit Eight: Metabolic Disorders
Samara University
Department of Biomedical Sciences
8/17/2022 1
Chapter 8: Metabolic Disorders
DR. MYM
Dr. Mohammed. Y (MD, Lecture)
2. Objectives
At the end of this session the student will be able to:
Describe Diabetes Mellitus
Disorder of calcium and uric acid metabolism
8/17/2022 2
Chapter 8: Metabolic disorder
DR. MYM
3. Definition of Diabetes
A heterogeneous disorder characterized by
abnormal carbohydrate, fat and protein
metabolism, secondary to resistance to the
action of insulin, absolute or relative
insufficient insulin secretion, or both resulting
in hyperglycaemia
Chapter 8: Metabolic disorder
DR. MYM
4. Diabetes = “siphon”or “running
through”
Large urine volume
Mellitus = sweet(Glucose in urine)
Chapter 8: Metabolic disorder
DR. MYM
Definition of Diabetes Cont…
5. Most important NCD
382 million people have diabetes
80% live in LMICs
Most affected age group – 40 to 59 years
175 million people are undiagnosed
5.1 million deaths in 2013 (1 death every 6 seconds)
Health care expenditure USD 548 billion ( 11% )
80% spent in rich countries
79,000 children developed type 1 diabetes in 2013
Chapter 8: Metabolic disorder
DR. MYM
Key Points on Diabetes
6. 2000 2013 2035
177 million 382 million 592 million
World Diabetes prevalence
Chapter 8: Metabolic disorder
DR. MYM
7. 2000 2013 2035
7.1 million 20 million 42 million
Diabetes prevalence in Africa
Chapter 8: Metabolic disorder
DR. MYM
8. 1982 2013 2035
0.34% 1.9 million 2.6 million
Diabetes prevalence in Ethiopia
Chapter 8: Metabolic disorder
DR. MYM
9. Most Common Metabolic Disease
Heterogeneous Disorders
Multiple Etiology
Disturbance Of Carbohydrate, Protein And Fat Metabolism
Hyperglycemia - Common Feature
Defects In Insulin Secretion, Action Or Both
Symptomatic & Asymptomatic Presentation
Prone to Acute & Chronic Complications
General Features of Diabetes
Chapter 8: Metabolic disorder
DR. MYM
10. Symptoms
Polydypsia
Polyuria
Polyphagia
Nocturia
Weight loss
Fatigue
Pruritus vulvae
Clinical Features
Amenorrhea
Slowly Healing Infections
Visual Problems
Pain in the Legs
Erectile Dysfunction
Signs
No Characteristic Features
Wasting & Dehydration
Evidence Of Complications
Chapter 8: Metabolic disorder
DR. MYM
12. Central obesity (Waist circumference 94 cm for men and 80
cm for women)
Plus
any two of the following four factors
1. TG 150 mg/dl, or specific treatment for this lipid abnormality
2. HDL <40 mg/l in males and <50 mg/l in females, or specific
treatment for this lipid abnormality
3. Systolic BP 130 or diastolic BP 85 mmHg, or treatment of
previously diagnosed hypertension
4. Fasting plasma glucose 100 mg/dl, or previously diagnosed
type 2 diabetes.
The Metabolic Syndrome Criteria
Chapter 8: Metabolic disorder
DR. MYM
13. Measure midway between lower costal margin & iliac crest
Sex IDF ATP
Males 94 102
Females 80 88
Waist Circumference (cm)
Chapter 8: Metabolic disorder
DR. MYM
14. Risk Factors for Diabetes
Age > 40 years
Strong Family History
Obesity (Diabesity)
Ethnicity (Blacks/Asians)
Previous GDM
Women Who Delivered Babies > 4
Kg
In Utero Under- & Over Nutrition
Previous IGT/IFG
Hypertension
Dyslipidemia
Chapter 8: Metabolic disorder
DR. MYM
15. Types Of Diabetes Mellitus
Type 1
Autoimmune – Type 1A
Idiopathic – Type 1B
Type 2
Predominantly Insulin Resistance
Predominantly Insulin Secretory Defects
Gestational Diabetes Mellitus
Other Specific Types
Chapter 8: Metabolic disorder
DR. MYM
16. Other Specific Types Of Diabetes
1. Genetic Defect Of Beta Cells e.g. MODY
2. Genetic Defects In Insulin Action e.g. Type A Insulin Resistance
3. Diseases Of The Exocrine Pancreas e.g. FCPP, Tumors
4. Endocrinopathies e.g. Acromegaly
5. Drug- Or Chemical Induced e.g. Steroids
6. Infections e.g. Congenital Rubella
7. Rare Immune-mediated Diabetes e.g. "Stiff-man" Syndrome
8. Other Genetic Syndromes e.g. Down's Syndrome
Chapter 8: Metabolic disorder
DR. MYM
17. Type 1A Diabetes Mellitus
Cellular Mediated Autoimmune Destruction Of Beta Cells
Markers Of Autoimmunity: ICA, IAA, Anti GAD Antibodies
Variable Rate Of Beta Cell Destruction
Acute Onset And Profound Symptoms
Age < 30 Years
Non-obese (Obesity Not Incompatible)
Ketonuria &/or Metabolic Acidosis
Immediate & Permanent Need For Insulin
No Microvascular Complications at Diagnosis
Prone to Other Autoimmune Diseases: Graves’, Hashimoto’s,
Addison’s Diseases, etc.
Chapter 8: Metabolic disorder
DR. MYM
18. Pathogenetic Progression of Type 1 Diabetes
B
Cell
Mass
Age yrs
Genetic
Predisposition
N insulin
secretion
Precipitating Event
Antibody +
N FBS
Overt Diabetes
C Peptide
Present C Peptide
Absent
Chapter 8: Metabolic disorder
DR. MYM
21. Type 1B Diabetes Mellitus
Young Patients
Abrupt Onset (Mean Duration Of Symptoms – 4 Days)
Prone To DKA Soon After Onset
No Insulitis on Biopsy/Autopsy
No Hyper-expression Of MHC Class I Molecules In Islets
No Diabetes-related Antibodies
Highly Elevated Serum Pancreatic Enzymes
Lymphocytic Infiltration Of The Exocrine Pancreas
No Classic Features of Acute/Chronic Pancreatitis
Chapter 8: Metabolic disorder
DR. MYM
22. Type 2 Diabetes Mellitus
Insulin Resistance
Relative Insulin Deficiency
Most are Obese/Abdominal Obesity
Symptomatic/Asymptomatic
Age > 40 Years
Positive Family History
Hyperosmolar Hyperglycemic State, DKA Very Rarely
Risk Increases With Age, Obesity, Sedentary Life Style, Prior GDM
Microvascular Complications May be Present at Diagnosis
Major Morbidity & Mortality From Macrovascular Disease
More Frequent in Persons With HPN & Dyslipidemias
Chapter 8: Metabolic disorder
DR. MYM
23. Pathogenesis of Type 2 Diabetes
β-cell Failure
Insulin
Resistance
Environment
Ageing
Pancreas
Muscle &
Adipose Tissue
IGT
Type 2 Diabetes
Genes
NGT or
Metabolic
Syndrome
80%
20%
Impaired
Incretin
Effect
24. Gestational Diabetes
Glucose intolerance which is first recognized in pregnancy
Complicates 3-7% of pregnancies
Onset usually at 24 - 28 weeks
97% disappears after delivery
Cause
Insulin resistance due to increased weight in pregnancy and
hormones
Complications:
Fetal death, HTN, UTI, premature birth, macrosomia,
hypoglycemia
Higher risk of type 2 DM later in life
Chapter 8: Metabolic disorder
DR. MYM
25. Differences B/n Type 1 & Type 2 DM
Type 1 Type 2
Prevalence 1% 5%
Onset Age Yrs. < 40 40
Symptoms Rapid &
Marked
Slow/ No
Genetics: 1st Degree
Monozygotic Concordance
< 10%
50 %
> 20%
90-100%
HLA Yes No
Autoimmunity Yes No
Body Build Lean Obese Or Normal
Metabolism DKA HHS
Treatment Insulin Tablets + Insulin
Chapter 8: Metabolic disorder
DR. MYM
26. Management Components
Education
Establish Targets
Diet
Exercise
Reduction of Risk Factors
Medications
Oral agents - Type 2
Insulin – Type 1 & Type 2
Chapter 8: Metabolic disorder
DR. MYM
27. Disorder of calcium and uric acid metabolism
8/17/2022 27
Chapter 8: Metabolic disorder
DR. MYM
28. Quiz2
1. Diabetes is a disturbance of carbohydrate metabolism that does not
affect the metabolism of lipids and proteins(T or F)
2. A family history of diabetes is more common in patients affected by
type 1diabetes than type 2(T or F)
3. One of the following is not a micro vascular complication of DM
A. Stroke C. Nephropathy
B. Retinopathy D. Neuropathy
4. DKA is more common is
A. Type 1 DM C. Gestational DM
B. Type 2 DM D. A&B
5. One of the following is diagnostic for DM
A. A random blood glucose e level 200mg /dl with profound
hyperglycemia(poly symptom)
B. A fasting glucose level of 110 mg /dl
C. A RBS level of 126 mg /dl
D. None
8/17/2022 28
Chapter 8: Metabolic disorder
DR. MYM
29. Reading Assignment
Disorder of calcium and uric acid metabolism
6. Elaborate Pathogenesis of severe complicated Malaria
8/17/2022 29
Chapter 8: Metabolic disorder
DR. MYM